Latest squamous cell carcinoma Stories
BOCA RATON, Fla., July 28, 2011 /PRNewswire/ -- Sensus Healthcare is pleased to announce that the Prince of Wales Hospital in Hong Kong has become the first healthcare facility in the country to purchase and deploy an SRT-100(TM) non-invasive skin cancer treatment system.
HAMILTON, N.J., July 20, 2011 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL) is a CLIA certified infectious disease laboratory which specializes in high-complexity, state-of-the-art, automated DNA-based molecular analyses.
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.
A new study published in the American Journal of Transplantation reveals an association between the human papillomavirus (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in organ transplant recipients.
CALGARY, July 6, 2011 /PRNewswire/ - Oncolytics Biotech Inc.
A key for early diagnosis of cancer and personalized medicine is the order of genetic aberrations - deviations or irregularity - in individual cancers.
Scientists have begun to reveal the order of the genetic aberrations in individual cancers in a finding they say is key to early diagnosis and personalized medicine.
â€œThese abstracts clearly confirm a role of PDT in the treatment of head and neck cancer.
BOCA RATON, Fla., May 24, 2011 /PRNewswire/ -- Sensus Healthcare is pleased to have exhibited at the 86th National Congress of SIDeMaST (The Italian Society of Dermatology) in Verona, Italy, May 18th - May 21st.
Researchers say they have discovered a new drug target for squamous cell carcinoma -- the second most common form of skin cancer.
- The act of sweetening by admixture of some saccharine substance.